drugset / Trial / NCT02813512

Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke

NCT02813512 ↗

Phase 1 Completed 3 enrolled Gwo Xi Stem Cell Applied Technology Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The objective of the study is to confirm the safety and possible efficacy of Adipose-Tissue Derived Stem Cells treatment of chronic stroke. Specifically, the study will transplant autologous ADSCs into brain surrounding ischemic infarct in adult (65-80 years old) subjects who have chronic non-hemorrhagic stroke (\>6 months).

Timeline

Start
2017-10-19
Primary completion
2018-11-27
Completion
2018-11-27

Drugs

EvaluationDrugModalityDoseRoute
Subject ADSCs Cell therapy 1e+08 cells Other

Indications